靶向癌症代谢作为提高治疗效果和克服耐药性的新策略。
Targeting Cancer Metabolism as a New Strategy to Enhance Treatment Efficacy and Overcome Resistance.
作者信息
Tucci Paola
机构信息
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, CS, Italy.
出版信息
Cancers (Basel). 2024 Oct 28;16(21):3629. doi: 10.3390/cancers16213629.
Abstract
The intricate relationship between metabolism and cancer has been a subject of growing interest in recent years, as metabolic reprogramming is recognized as one of the hallmarks of cancer [...].
摘要
近年来，新陈代谢与癌症之间的复杂关系一直是人们日益关注的主题，因为代谢重编程被认为是癌症的标志之一[...]。
相似文献
1
Targeting Cancer Metabolism as a New Strategy to Enhance Treatment Efficacy and Overcome Resistance.
Cancers (Basel). 2024 Oct 28;16(21):3629. doi: 10.3390/cancers16213629.
2
Targeting metabolism in breast cancer: How far we can go?
World J Clin Oncol. 2016 Feb 10;7(1):122-30. doi: 10.5306/wjco.v7.i1.122.
3
Relationship between metabolic reprogramming and drug resistance in breast cancer.
Front Oncol. 2022 Aug 18;12:942064. doi: 10.3389/fonc.2022.942064. eCollection 2022.
4
Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
Biomolecules. 2020 Jan 14;10(1):135. doi: 10.3390/biom10010135.
5
Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways.
Biochem Pharmacol. 2018 May;151:114-125. doi: 10.1016/j.bcp.2018.03.006. Epub 2018 Mar 9.
6
Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma.
Drug Resist Updat. 2022 Mar;61:100822. doi: 10.1016/j.drup.2022.100822. Epub 2022 Mar 4.
7
The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer.
Front Oncol. 2020 Jun 11;10:942. doi: 10.3389/fonc.2020.00942. eCollection 2020.
8
Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines.
Cancers (Basel). 2020 Feb 10;12(2):404. doi: 10.3390/cancers12020404.
9
Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review.
J Oncol. 2022 Sep 5;2022:4257359. doi: 10.1155/2022/4257359. eCollection 2022.
10
Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC.
Adv Sci (Weinh). 2024 Dec;11(46):e2401399. doi: 10.1002/advs.202401399. Epub 2024 Oct 25.
引用本文的文献
1
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.
Cancer Drug Resist. 2025 Feb 8;8:7. doi: 10.20517/cdr.2024.164. eCollection 2025.
本文引用的文献
1
Modulation of energetic and lipid pathways by curcumin as a potential chemopreventive strategy in human prostate cancer cells.
Biochem Biophys Res Commun. 2024 Nov 26;735:150477. doi: 10.1016/j.bbrc.2024.150477. Epub 2024 Jul 30.
2
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.
Br J Cancer. 2024 Mar;130(4):568-584. doi: 10.1038/s41416-023-02553-y. Epub 2023 Dec 30.
3
Targeting glutamine metabolism as a therapeutic strategy for cancer.
Exp Mol Med. 2023 Apr;55(4):706-715. doi: 10.1038/s12276-023-00971-9. Epub 2023 Apr 3.
4
Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation.
Cells. 2021 Apr 29;10(5):1056. doi: 10.3390/cells10051056.
5
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.
Mol Cancer Ther. 2018 Jul;17(7):1355-1364. doi: 10.1158/1535-7163.MCT-17-1299.
6
Metabolic reprogramming in clear cell renal cell carcinoma.
Nat Rev Nephrol. 2017 Jul;13(7):410-419. doi: 10.1038/nrneph.2017.59. Epub 2017 May 8.
7
Strategies to overcome therapeutic resistance in renal cell carcinoma.
Urol Oncol. 2017 Mar;35(3):102-110. doi: 10.1016/j.urolonc.2016.12.002. Epub 2017 Jan 11.
8
Serine and one-carbon metabolism in cancer.
Nat Rev Cancer. 2016 Oct;16(10):650-62. doi: 10.1038/nrc.2016.81. Epub 2016 Sep 16.
9
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.
N Engl J Med. 2016 Sep 1;375(9):819-29. doi: 10.1056/NEJMoa1604958. Epub 2016 Jul 13.
10
Serine, glycine and one-carbon units: cancer metabolism in full circle.
Nat Rev Cancer. 2013 Aug;13(8):572-83. doi: 10.1038/nrc3557. Epub 2013 Jul 4.
Zotero 插件